Literature DB >> 22422356

The importance and value of EQA for diagnostic genetic laboratories.

Ros J Hastings1, Rod T Howell.   

Abstract

Quality control in a laboratory setting requires the establishment of effective training, standard operating procedures, internal quality control, validation of tests and external quality assessment (EQA). A structured quality management system subject to regular internal and external audits will minimise the error rate. EQA, therefore, gives assurance, both to patients and referring clinicians, that the diagnostic laboratory is competent to produce results that are reliable and accurate. EQA is educational and aims to improve and validate the overall quality of genetic service to the user. Regular EQA assessment compares laboratory performance against set standards and also allows comparison between laboratories. Sometimes EQA can also help to define good standards (best practice), although this does depend on the type of EQA test. EQA interprets best practice standards (=quality) into a numerical score (=quantity). While international bodies or professional organisations set these standards, EQA is able to assess whether these standards are met, with any omissions resulting in a reduction in the total score. Although EQA has an educational role rather than a punitive role, critical errors affecting clinical management will result in a laboratory receiving a poor performance categorisation. Accurate analysis and interpretation are essential quality parameters that require extensive knowledge of the aetiology of genetic abnormalities/disease and risk factors. Training of staff in interpretation of the results together with a comprehensive means of reporting normal and abnormal genetic results underpins the diagnostic service to the patient. Poor-performing laboratories are, therefore, encouraged to review their internal processes. EQA schemes that have been established for many years have seen improvements in the analytical and reporting content over time, thereby improving the quality of diagnostic service available to patients.

Entities:  

Year:  2010        PMID: 22422356      PMCID: PMC3185976          DOI: 10.1007/s12687-010-0009-x

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  7 in total

1.  External Quality Assessment Schemes: need for recognised requirements.

Authors:  L Sciacovelli; S Secchiero; L Zardo; M Plebani
Journal:  Clin Chim Acta       Date:  2001-07-20       Impact factor: 3.786

Review 2.  Quality control in molecular genetic testing.

Authors:  E Dequeker; S Ramsden; W W Grody; T T Stenzel; D E Barton
Journal:  Nat Rev Genet       Date:  2001-09       Impact factor: 53.242

3.  Cytogenetic Guidelines and Quality Assurance: a common European framework for quality assessment for constitutional and acquired cytogenetic investigations.

Authors:  Ros J Hastings; Simona Cavani; Franca Dagna Bricarelli; Philippos C Patsalis; Ulf Kristoffersson
Journal:  Eur J Hum Genet       Date:  2007-03-14       Impact factor: 4.246

4.  An Internet-based external quality assessment in cytogenetics that audits a laboratory's analytical and interpretative performance.

Authors:  Rosalind J Hastings; Eddy J Maher; Bettina Quellhorst-Pawley; Rodney T Howell
Journal:  Eur J Hum Genet       Date:  2008-05-21       Impact factor: 4.246

5.  FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib.

Authors:  U Reinhold; E Hennig; S Leiblein; D Niederwieser; M W N Deininger
Journal:  Leukemia       Date:  2003-10       Impact factor: 11.528

6.  Quality of analytical performance in inherited metabolic disorders: the role of ERNDIM.

Authors:  B Fowler; A Burlina; V Kozich; C Vianey-Saban
Journal:  J Inherit Metab Dis       Date:  2008-11-21       Impact factor: 4.982

7.  Personnel standards and quality assurance practices of biochemical genetic testing laboratories in the United States.

Authors:  Margaret M McGovern; Marta Benach; Sylvan Wallenstein; Joe Boone; Ira M Lubin
Journal:  Arch Pathol Lab Med       Date:  2003-01       Impact factor: 5.534

  7 in total
  5 in total

1.  Evaluation of staff performance and interpretation of the screening program for prevention of thalassemia.

Authors:  Simaporn Prommetta; Kanokwan Sanchaisuriya; Goonnapa Fucharoen; Supawadee Yamsri; Attawut Chaiboonroeng; Supan Fucharoen
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

2.  Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in India.

Authors:  Omshree Shetty; Tanuja Shet; Ramya Iyer; Prachi Gogte; Mamta Gurav; Pradnya Joshi; Nupur Karnik; Trupti Pai; Sridhar Epari; Sangeeta Desai
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

3.  The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Does Active Participation Improve the Quality?

Authors:  Marco Salvatore; Annalisa Amato; Giovanna Floridia; Federica Censi; Gianluca Ferrari; Fabrizio Tosto; Rita Padoan; Valeria Raia; Natalia Cirilli; Giuseppe Castaldo; Ettore Capoluongo; Ubaldo Caruso; Carlo Corbetta; Domenica Taruscio
Journal:  Int J Environ Res Public Health       Date:  2020-05-04       Impact factor: 3.390

4.  The International Collaboration for Cancer Classification and Research.

Authors:  Ian A Cree; Blanca Iciar Indave Ruiz; Jiri Zavadil; James McKay; Magali Olivier; Zisis Kozlakidis; Alexander J Lazar; Chris Hyde; Stefan Holdenrieder; Ros Hastings; Nasir Rajpoot; Arnaud de la Fouchardiere; Brian Rous; Jean Claude Zenklusen; Nicola Normanno; Richard L Schilsky
Journal:  Int J Cancer       Date:  2020-10-09       Impact factor: 7.396

5.  The Italian National External quality assessment program in molecular genetic testing: results of the VII round (2010-2011).

Authors:  F Censi; F Tosto; G Floridia; M Marra; M Salvatore; A M Baffico; M Grasso; M A Melis; E Pelo; P Radice; A Ravani; C Rosatelli; N Resta; S Russo; M Seia; L Varesco; V Falbo; D Taruscio
Journal:  Biomed Res Int       Date:  2013-01-29       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.